News
UBS Maintains Neutral on BioNTech, Lowers Price Target to $101
27 Mar 24
News, Price Target, Analyst Ratings
JP Morgan Maintains Underweight on BioNTech, Lowers Price Target to $90
22 Mar 24
News, Price Target, Analyst Ratings
BMO Capital Maintains Outperform on BioNTech, Lowers Price Target to $123
21 Mar 24
News, Price Target, Analyst Ratings
Cracking The Code: Understanding Analyst Reviews For BioNTech
21 Mar 24
Analyst Ratings
Canaccord Genuity Reiterates Buy on BioNTech, Maintains $171 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
20 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
20 Mar 24
Biotech, News, Markets, General
Why Is BioNTech Stock Trading Lower On Wednesday?
20 Mar 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Movers, General
US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top'
20 Mar 24
Earnings, Equities, News, Futures, Previews, Top Stories, Economics, Federal Reserve, Pre-Market Outlook, Markets, Movers, Trading Ideas
BioNTech Q4 GAAP EPS $2.04 Misses $2.64 Estimate, Sales $1.59B Miss $1.99B Estimate
20 Mar 24
Earnings, News
Earnings Scheduled For March 20, 2024
20 Mar 24
Earnings
5 Value Stocks In The Healthcare Sector
4 Mar 24
News
Goldman Sachs Maintains Neutral on BioNTech, Lowers Price Target to $100
28 Feb 24
News, Price Target, Analyst Ratings
Canaccord Genuity Reiterates Buy on BioNTech, Maintains $171 Price Target
23 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Canaccord Genuity Reiterates Buy on BioNTech, Maintains $171 Price Target
21 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Cracking The Code: Understanding Analyst Reviews For BioNTech
20 Feb 24
Analyst Ratings
Canaccord Genuity Maintains Buy on BioNTech, Raises Price Target to $171
20 Feb 24
News, Price Target, Analyst Ratings
Overview Of Value Stocks In The Healthcare Sector
12 Feb 24
News
MHRA Announced Approvals for Comirnaty (Pfizer/BioNTech), Nuvaxovid (Novavax) COVID-19 Vaccines
9 Feb 24
News, FDA
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
8 Feb 24
News
Press releases
WuXi Biologics Reports Solid 2023 Annual Results
26 Mar 24
Earnings, Press Releases
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
26 Mar 24
News, Press Releases
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
20 Mar 24
Press Releases
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
20 Mar 24
Press Releases
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
12 Mar 24
Press Releases
Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky
12 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX
11 Mar 24
Press Releases
BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
11 Mar 24
News, Legal, Press Releases
FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against BioNTech SE (BNTX)
11 Mar 24
News, Legal, Press Releases
DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
11 Mar 24
News, Legal, Press Releases
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioNTech SE (BNTX)
11 Mar 24
Press Releases
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
11 Mar 24
Press Releases
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX
11 Mar 24
Press Releases
BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
11 Mar 24
News, Legal, Press Releases
BIONTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioNTech SE and Encourages Investors to Contact the Firm
8 Mar 24
News, Legal, Press Releases
BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit
8 Mar 24
Press Releases
Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
7 Mar 24
Press Releases
BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
7 Mar 24
News, Legal, Press Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioNTech SE (BNTX)
7 Mar 24
News, Legal, Press Releases
DEADLINE ALERT: Bernstein Liebhard LLP Reminds BioNTech SE Investors of Upcoming Deadline
7 Mar 24
News, Legal, Press Releases